1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |

---

The findings of a study published in Nature Communications have shown that B cells might play an important role in immunotherapy for melanoma. Currently, immunotherapy is primarily focused on T cells, but the results suggest th...

Read More

---

Two Dose HPV Vaccination schedule can Provide Long Term Immunogenicity

Release Date: 05 October 2019

A recent study published in the journal Clinical Infectious diseases shows that a 2-dose schedule of human papillomavirus (HPV) vaccination in girls was proportional to 3 doses schedule, for a period of about 10 years. The study was perf...

Read More

---

Topical Immunotherapy can Control Skin Cancer

Release Date: 05 October 2019

Recently, the findings of a study is published in JCI insight confirmed that the Topical immunotherapy may help prevent the second most common type of skin cancer. the researcher team involves the Researchers from Washington University S...

Read More

---

AGI 134 Second Part of Phase 1/2 Study is initiated for Solid Tumor Management

Release Date: 05 October 2019

On 25 September 2019, BioLineRx Ltd. announced that the dosing of the first patient in part 2 of the Phase 1/2a clinical study for AGI-134 is initiated. BiolineRx is a clinical-stage biopharmaceutical company, which...

Read More

---

New Long Acting Implants for HIV Drug Delivery

Release Date: 05 October 2019

Recently, a new HIV drug Delivery system is prepared by the group of researchers from the University of North Carolina (UNC) at Chapel Hill. The prepared system is an ultra-long-acting tunable, biodegradable, and removable polymer-based ...

Read More

---

New Microcapsules Can Provide Safe and Effective Bimolecular Drug Delivery

Release Date: 05 October 2019

Recently, a team of researchers at Harvard's Wyss Institute for Biologically Inspired Engineering and John A. Paulson School of Engineering and Applied Sciences (SEAS), created an advanced type of microcapsules that can deliver the drug ...

Read More

---

Keytruda – Merck’s Checkpoint Inhibitor Got Approval as Monotherapy in China

Release Date: 05 October 2019

On 2 October 2019, Merck announced that Keytruda got approval as a first line monotherapy by the National Medical Products Administration (NMPA) in China. The approval of Keytruda is related to the management of locally advanced or metas...

Read More

---

Innate Pharma’s IPH5401 With Durvalumab shows Prominent Action in Phase I Trial Against Solid Tumor

Release Date: 05 October 2019

On 1 October 2019, Innate Pharma SA announced that new data of Phase I Trial on IPH5401 and Durvalumab combination, which was presented at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona,...

Read More

---

Preclinical Data of BiCKI® shows promising action in Tumor Resistance

Release Date: 04 October 2019

Recently, At International Cancer Immunotherapy Conference (CICON), OSE Immunotherapeutics presented a new data on BiCKIandreg; platform, in Paris, France. BiCKI antibody is based on the anti-PD-1 activity. The first cytokine selected to...

Read More

---

Anakinra – A new Therapeutic For Autoimmune Associated Cytokine Storm

Release Date: 04 October 2019

Recently, a research team led Randy Q. Cron, MD, PhD, and colleagues from the University of Alabama at Birmingham School of Medicine, the interleukin (IL)-1 receptor antagonist Anakinra (Kineret) showed promising action against the as se...

Read More

---

IL-36 can control Blood Sugar Level

Release Date: 04 October 2019

According to the findings of a new research published in the Journal of Nature Communications, the patients with high levels of the protein, IL-36 cytokines, were found to have lower blood sugar levels, in the case of type 2 Diabetes. It...

Read More

---

Fate Therapeutics Initiated cGMP for iPSC Derived Cell Therapies

Release Date: 04 October 2019

Recently, On 30 September 2019, Fate Therapeutics, Inc., initiated current Good Manufacturing Process (cGMP) compliant manufacturing facility for the clinical production of iPSC derived products such as natural killer (NK) cell and chime...

Read More

---

Brentuximab Vedotin – Highly Effective Therapeutic for Hodgkin’s Lymphoma

Release Date: 04 October 2019

Recently, a study presented in the ESMO 2019 in Barcelona, Spain, indicates that Brentuximab vedotin improves the therapeutic response and prolongs progression-free survival (PFS) in patients with Hodgkin lymphoma. This therapeutic is ac...

Read More

---

BCG Vaccination Can Reduce the Probability of Lung Cancer

Release Date: 04 October 2019

According to the study published in JAMA Network Online, a Common vaccine of tuberculosis known as BCG vaccine can decrease the risk of lung cancer if administered during early childhood. The study was published on 25 September 2019. The...

Read More

---

Glenmark’s GBR-1342 Get Orphan Drug Designation

Release Date: 03 October 2019

The new Bispecific antibody candidate of Glenmark Pharmaceuticals is granted an Orphan Drug Designation (ODD) from USFDA. The ODD is granted for the treatment of patients with multiple myeloma who have received prior therapies. This Bisp...

Read More

---

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |